SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 119.53 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 65.28 |
| Book Value / Share | 1.11 |
| Price / Book | n/a |
| NCAV ($M) | 59.22 |
| NCAV / Share | 1.01 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.86 |
| Return on Assets (ROA) | -0.44 |
| Return on Equity (ROE) | -0.48 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.61 |
| Current Ratio | 5.31 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 73.62 |
| Assets | 79.69 |
| Liabilities | 14.41 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Tang Capital Partners Lp | 3.20 | -37.54 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 131,525 | 590,097 | 22.29 | |
| 648,564 | 2,051,164 | 31.62 | |
| 44,401 | 158,826 | 27.96 | |
| 30,353 | 108,241 | 28.04 | |
| 23,807 | 133,417 | 17.84 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IBRX – ImmunityBio, Inc. | IDXX – IDEXX Laboratories, Inc. |
| IDYA – IDEAYA Biosciences, Inc. | IGMS – IGM Biosciences, Inc. |
| IMUX – Immunic, Inc. |
Financial data and stock pages provided by
Fintel.io